101 related articles for article (PubMed ID: 11776809)
1. [Glutathione synthesis inhibitor enhances arsenic trioxide-induced apoptosis].
Shen Y; Chen G; Cai X
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):259-61. PubMed ID: 11776809
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z
Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429
[TBL] [Abstract][Full Text] [Related]
4. [The mechanisms of arsenic trioxide-induced apoptosis in hematopoietic malignant cells].
Cai X; Chen G; Jia P
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):452-5. PubMed ID: 11715442
[TBL] [Abstract][Full Text] [Related]
5. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
Chen D; Chan R; Waxman S; Jing Y
Cancer Res; 2006 Dec; 66(23):11416-23. PubMed ID: 17145888
[TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells].
Zhou Y; Huang X; Cai X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):181-3. PubMed ID: 11783079
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
[TBL] [Abstract][Full Text] [Related]
8. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
Maeda H; Hori S; Ohizumi H; Segawa T; Kakehi Y; Ogawa O; Kakizuka A
Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
Kitamura K; Minami Y; Yamamoto K; Akao Y; Kiyoi H; Saito H; Naoe T
Leukemia; 2000 Oct; 14(10):1743-50. PubMed ID: 11021749
[TBL] [Abstract][Full Text] [Related]
11. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
Gu S; Chen C; Jiang X; Zhang Z
Wei Sheng Yan Jiu; 2016 Jan; 45(1):87-92. PubMed ID: 26987203
[TBL] [Abstract][Full Text] [Related]
12. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):438-43. PubMed ID: 18072624
[TBL] [Abstract][Full Text] [Related]
13. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
Dai J; Weinberg RS; Waxman S; Jing Y
Blood; 1999 Jan; 93(1):268-77. PubMed ID: 9864170
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between sensitivity to arsenic trioxide and antioxidative capacity of malignant hematopoietic cells].
Zhu Q; Chen G; Huang Y
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):359-61. PubMed ID: 11778267
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
Seo T; Urasaki Y; Takemura H; Ueda T
Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
[TBL] [Abstract][Full Text] [Related]
17. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
Ong PS; Chan SY; Ho PC
Int J Oncol; 2011 Jun; 38(6):1731-9. PubMed ID: 21455570
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
Han YH; Kim SZ; Kim SH; Park WH
Mol Cells; 2008 Aug; 26(2):158-64. PubMed ID: 18596414
[TBL] [Abstract][Full Text] [Related]
19. [Regulation of arsenic trioxide-inducing apoptosis].
Huang X
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):258-60. PubMed ID: 11601217
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
